Page last updated: 2024-09-05

mcc-555 and Diabetes Mellitus, Adult-Onset

mcc-555 has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, G; Lin, M; Lu, G; Sun, N; Wu, Y1
Foster, JR; Pickavance, LC; Widdowson, PS; Wilding, JP; Williams, G1
Ishii, S; King, P; Pickavance, L; Tanaka, H; Widdowson, PS; Williams, G1

Other Studies

3 other study(ies) available for mcc-555 and Diabetes Mellitus, Adult-Onset

ArticleYear
High-throughput quantification of a novel thiazolidinedione MCC-555 in rat plasma by ultra-fast liquid chromatography and its application in pharmacokinetic studies.
    Talanta, 2009, Apr-30, Volume: 78, Issue:2

    Topics: Animals; Chromatography, Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Pharmacokinetics; Rats; Thiazolidinediones

2009
Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.
    International journal of experimental pathology, 2003, Volume: 84, Issue:2

    Topics: Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Administration Schedule; Insulin; Islets of Langerhans; Male; Nitric Oxide Synthase; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones

2003
The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
    British journal of pharmacology, 1998, Volume: 125, Issue:4

    Topics: Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Drinking; Glucose; Glucose Intolerance; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Time Factors

1998